CHMP turns down Kynamro
December 17, 2012Sales and Marketing CHMP, Genzyme, Kynamro, Sanofi
Genzyme has expressed frustration at the CHMP’s negative opinion of its novel drug Kynamro, and plans to ask it to …
Signifor approved in US
December 17, 2012Sales and Marketing Cushing's, Novartis, Signifor
Novartis’ injection Signifor has been approved by the FDA to treat Cushing’s disease, a rare but serious endocrine disorder affecting …
Swiss Re helps Roche open up China’s oncology market
December 17, 2012Sales and Marketing Cancer, China, Roche, Swiss re, oncology
Roche and reinsurance firm Swiss Re have teamed up to find an innovative way into China’s healthcare market. For the …
Amgen appoints Mattel’s Robert Eckert to Board of directors
December 14, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Eckert
Biotech firm Amgen has announced the appointment of Robert Eckert, former chief executive officer at Mattel, to its Board of …
RA setbacks for AstraZeneca and Lilly
December 14, 2012Research and Development, Sales and Marketing AstraZeneca, Humira, RA, lilly
AstraZeneca and Eli Lilly have both suffered setbacks in their attempts to push their respective investigational rheumatoid arthritis (RA) treatments …
Revlimid patient scheme ‘working’
December 14, 2012Sales and Marketing Celgene, Revlimid
Celgene has issued figures which it says demonstrate the clinical value of the NICE-agreed patient access scheme for its cancer …
David Stack appointed to Amarin Board of directors
December 14, 2012Manufacturing and Production, Research and Development, Sales and Marketing Amarin, David Stack
Biopharma firm Amarin has confirmed that David Stack, president and chief executive of Pacira Pharmaceuticals, has joined its Board of …
Board consults on specialised services
December 13, 2012Sales and Marketing CF, NHS CB, Sickle cell
The NHS Commissioning Board has launched a consultation into how the NHS provides specialised services, including treatments for conditions such …
‘Augmented reflection’ brings GAD to life
December 13, 2012Medical Communications GAD, Pfizer, You Tube
Pfizer has worked with patient group Anxiety UK to create a new ‘enhanced reflection’ video to raise awareness of Generalised …
Hold tight: a bumpy ride ahead for the NHS
December 13, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hunt, Lansley, NHS, Wallards, reforms
The Wellards Annual Conference is an event where two worlds – the industry and the NHS – meet for a …
Stevenage Bioscience Catalyst hires first entrepreneur-in-residence
December 13, 2012Manufacturing and Production, Research and Development, Sales and Marketing Stevenage Bioscience Catalyst
Early-stage biotech firm Stevenage Bioscience Catalyst (SBC) has appointed Dr Barbara Domayne-Hayman as its first entrepreneur-in-residence. Domayne-Hayman will work with …
Eliquis in UK for AF
December 13, 2012Sales and Marketing AF, BMS, Eliquis, NVAF, Pfizer
Eliquis has been made available in the UK today to prevent stroke and systemic embolism in patients with nonvalvular atrial …
New managing director for Lilly UK
December 12, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing lilly
Lilly UK has appointed Dr Jean-Michel Cosséry as the new managing director and VP of the UK Affiliate and the …
Almac Group appoints Charlie Morris to executive team
December 12, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almac Group
The Almac Group’s Clinical Technologies business unit has announced that Charlie Morris has joined the company as vice president of …
Switzerland first to pass EU’s ‘equivalence’ test for APIs
December 12, 2012Manufacturing and Production API, China, EU, FMD, MHRA
Switzerland has become the first country to be classed as having equivalent standards for the manufacture of active pharmaceutical ingredients …
Novartis blood cancer hope
December 12, 2012Research and Development, Sales and Marketing Jakavi, Novartis, oncology
Two-year data from Novartis’s drug Jakavi suggests that it may improve overall survival in a rare form of cancer versus …
Roche plans €200m investment in diagnostics facility
December 12, 2012Manufacturing and Production Diagnostics, Roche
Roche has said it intends to invest more than €200 million ($260m) in the construction of a new production plant …
SMC first to give Fycompa thumbs-up
December 12, 2012Sales and Marketing Eisai, Fycompa, SMC, Scotland, epilepsy
The Scottish Medicines Consortium (SMC) has approved Eisai’s first-in-class epilepsy drug Fycompa for use in the NHS in Scotland – …
Hanover Communications hires associate director
December 12, 2012Medical Communications, Sales and Marketing Hanover, Jim Baxter
Hanover Communications has announced the appointment of Jim Baxter to its Healthcare division in order to expand into the brand …
Contract research news in brief
December 12, 2012Research and Development AMRI, Covance, Dimensione Ricerca, INC Research, Perceptive Informatics, TFS
TFS buys Italian CRO Dimensione Ricerca, AMRI closes a US facility plus business development updates from Covance, Perceptive Informatics and …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
